Prosperity Consulting Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.02M Buy
27,908
+1,622
+6% +$349K 0.27% 69
2026
Q1
$5.72M Sell
26,286
-429
-2% -$95.2K 0.25% 74
2025
Q4
$6.1M Buy
26,715
+150
+0.6% +$34.2K 0.27% 65
2025
Q3
$6.15M Buy
26,565
+800
+3% +$163K 0.3% 61
2025
Q2
$4.78M Sell
25,765
-642
-2% -$119K 0.35% 67
2025
Q1
$5.53M Sell
26,407
-207
-0.8% -$40.2K 0.43% 53
2024
Q4
$4.73M Buy
26,614
+187
+0.7% +$34.4K 0.36% 68
2024
Q3
$5.22M Buy
26,427
+2,651
+11% +$495K 0.41% 60
2024
Q2
$4.08M Sell
23,776
-6,498
-21% -$1.08M 0.55% 48
2024
Q1
$5.51M Buy
30,274
+21,304
+238% +$3.67M 0.69% 36
2023
Q4
$1.39M Buy
8,970
+981
+12% +$143K 0.47% 49
2023
Q3
$1.19M Buy
7,989
+5,978
+297% +$878K 0.55% 46
2023
Q2
$271K Buy
2,011
+11
+0.6% +$1.61K 0.17% 90
2023
Q1
$319K Sell
2,000
-59
-3% -$9.02K 0.2% 84
2022
Q4
$333K Buy
+2,059
New +$316K 0.22% 78
2022
Q3
Sell
-1,862
Closed -$285K 97
2022
Q2
$285K Sell
1,862
-18
-1% -$2.75K 0.25% 70
2022
Q1
$305K Sell
1,880
-1
-0.1% -$145 0.23% 76
2021
Q4
$261K Buy
+1,881
New +$222K 0.2% 86

Other funds holding ABBV

Prosperity Consulting Group's ABBV Position: Q2 2026 in Review

Prosperity Consulting Group increased its AbbVie (ABBV) stake by 6.2% in Q2 2026, buying an estimated $349K and bringing the position to 27,908 shares worth $7.02M. The position accounts for 0.27% of the portfolio, ranked #69.

Prosperity Consulting Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prosperity Consulting Group held 27,908 shares of AbbVie worth $7.02M as of Q2 2026.
  • Prosperity Consulting Group bought 1,622 AbbVie shares in Q2 2026, an estimated $349K.
  • AbbVie made up 0.27% of Prosperity Consulting Group's portfolio in Q2 2026, its #69 holding.
  • Prosperity Consulting Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.